Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Ion sequential therapy improves heart function after a heart attack.

The new drug delivery system effectively targets lung cancer cells.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

New treatments improved blood pressure control in patients with resistant hypertension.

Erlotinib can cause hair loss and texture changes.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Antizyme slows skin tumor growth by reducing cell growth in mice.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.